PROSOMNUS, INC.
CIK 0001934064
Revenue (TTM)
$30.56M
+42.6% YoY
Q2 Jul 2024
Net Income (TTM)
−$22.07M
−237.2% YoY
Q2 Jul 2024
EPS Diluted (TTM)
−$1.60
−109.9% YoY
Q2 Jul 2024
Gross Margin
41.8%
Q2 Jul 2024
Operating Margin
-45.8%
Q2 Jul 2024
Net Margin
-72.2%
Q2 Jul 2024
Free Cash Flow (TTM)
−$17.59M
Q2 Jul 2024
Cash
$4.61M
Q2 Jul 2024
Total Debt
$158K
Q2 Jul 2024
Shares Outstanding
17.39M sh
Q2 Jul 2024